| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ABVX
Abivax SA Sponsored ADR
|
Jun 01, 2026 | HOLD |
Strong Buy
+20.7% avg upside
15 analysts
|
$90.00
9.21% Downside
|
-22.8% |
|
PTCT
PTC Therapeutics
|
May 27, 2026 | BUY |
Strong Buy
-1.4% avg upside
29 analysts
|
$85.00
7.62% Upside
|
+11.1% |
|
ONC
BeOne Medicines
|
May 21, 2026 | HOLD |
Strong Buy
+28.6% avg upside
28 analysts
|
$333.00
23.34% Upside
|
-15.2% |
|
SMMT
Summit Therapeutics
|
May 21, 2026 | HOLD |
Strong Buy
+112.6% avg upside
27 analysts
|
$17.00
23.65% Upside
|
-20.6% |
|
ASND
Ascendis Pharma
|
May 06, 2026 | BUY |
Strong Buy
+16.9% avg upside
24 analysts
|
$290.00
25.73% Upside
|
-5.3% |
|
SNDX
Syndax Pharmaceuticals
|
May 01, 2026 | BUY |
Strong Buy
+88.7% avg upside
27 analysts
|
$37.00
94.67% Upside
|
-4.1% |
|
RVMD
Revolution Medicines
|
Apr 10, 2026 | BUY |
Strong Buy
-12.2% avg upside
32 analysts
|
$140.00
14.11% Downside
|
+63.6% |
|
VSTM
Verastem
|
Mar 30, 2026 | BUY |
Strong Buy
+259.4% avg upside
23 analysts
|
$15.00
264.12% Upside
|
-17.5% |
|
FDMT
4D Molecular Therapeutics
|
Mar 30, 2026 | BUY |
Strong Buy
+266.1% avg upside
15 analysts
|
$21.00
117.35% Upside
|
+6.8% |
|
VRDN
Viridian Therapeutics
|
Mar 30, 2026 | BUY |
Strong Buy
+103.6% avg upside
32 analysts
|
$29.00
74.32% Upside
|
-13.1% |
|
ANIP
ANI Pharmaceuticals
|
Mar 25, 2026 | BUY |
Strong Buy
+28.6% avg upside
11 analysts
|
$120.00
50.99% Upside
|
+5.3% |
|
INSM
Insmed
|
Mar 17, 2026 | BUY |
Strong Buy
+82.1% avg upside
36 analysts
|
$228.00
138.04% Upside
|
-31.6% |
|
COGT
Cogent Biosciences
|
Mar 16, 2026 | BUY |
Strong Buy
+7.4% avg upside
26 analysts
|
$55.00
59.17% Upside
|
-4.1% |
|
ALNY
Alnylam Pharma
|
Mar 15, 2026 | HOLD |
Strong Buy
+23.4% avg upside
51 analysts
|
$330.00
18.60% Upside
|
-11.3% |
|
INCY
Incyte
|
Mar 15, 2026 | HOLD |
Buy
+1.0% avg upside
47 analysts
|
$94.00
4.28% Downside
|
+6.4% |
|
IMTX
Immatics
|
Mar 15, 2026 | BUY |
Strong Buy
+87.3% avg upside
15 analysts
|
$18.00
84.11% Upside
|
+10.8% |
|
KYMR
Kymera Therapeutics
|
Mar 15, 2026 | BUY |
Strong Buy
+9.0% avg upside
36 analysts
|
$110.00
21.66% Upside
|
+7.5% |
|
IMCR
Immunocore Holdings
|
Mar 15, 2026 | HOLD |
Strong Buy
+124.5% avg upside
22 analysts
|
$33.00
15.34% Upside
|
-8.2% |
|
DSGN
Design Therapeutics
|
Mar 15, 2026 | BUY |
Strong Buy
+45.3% avg upside
9 analysts
|
$15.00
20.51% Upside
|
+30.8% |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
Dec 15, 2025 | BUY |
Strong Buy
+70.7% avg upside
8 analysts
|
$21.00
75.95% Upside
|
+10.6% |
|
RYTM
Rhythm Pharmaceuticals
|
Dec 15, 2025 | BUY |
Strong Buy
+25.2% avg upside
19 analysts
|
$142.00
46.62% Upside
|
-14.8% |
|
ABCL
AbCellera Biologics
|
Nov 07, 2025 | HOLD |
Strong Buy
+139.4% avg upside
15 analysts
|
$4.00
27.61% Downside
|
+12.8% |
|
NRIX
Nurix Therapeutics
|
Oct 23, 2025 | HOLD |
Strong Buy
+76.3% avg upside
26 analysts
|
$12.00
31.71% Downside
|
+69.1% |
|
LKFT
Lakefront Biotherapeutics
|
Oct 22, 2025 | BUY |
Hold
+272.9% avg upside
24 analysts
|
$40.00
41.29% Upside
|
· |
|
MNKD
MannKind
|
Oct 10, 2025 | BUY |
Buy
+78.6% avg upside
22 analysts
|
$9.00
128.38% Upside
|
-32.2% |
|
ATYR
aTyr Pharma
|
Sep 30, 2025 | HOLD |
Buy
+2016.8% avg upside
17 analysts
|
— | -27.9% |
|
ZURA
Zura Bio
|
Sep 30, 2025 | BUY |
Strong Buy
+289.3% avg upside
12 analysts
|
— | -18.8% |
|
PRTCY
PureTech Health
|
Sep 30, 2025 | BUY |
Strong Buy
+194.2% avg upside
3 analysts
|
— | · |
|
TRVI
Trevi Therapeutics
|
Sep 29, 2025 | BUY |
Strong Buy
+17.9% avg upside
16 analysts
|
— | +58.7% |
|
IMUX
Immunic
|
Sep 25, 2025 | BUY |
Strong Buy
+166.2% avg upside
21 analysts
|
— | +54.3% |
|
PTGX
Protagonist Therapeutics
|
Sep 18, 2025 | BUY |
Strong Buy
-22.1% avg upside
19 analysts
|
— | +79.3% |
|
SYRE
Spyre Therapeutics
|
Sep 11, 2025 | BUY |
Strong Buy
-15.4% avg upside
23 analysts
|
— | +415.9% |
|
STTK
Shattuck Labs
|
Aug 18, 2025 | BUY |
Strong Buy
+369.1% avg upside
14 analysts
|
$2.00
59.52% Downside
|
+324.5% |
|
GERN
Geron
|
Aug 12, 2025 | BUY |
Strong Buy
+240.0% avg upside
19 analysts
|
$3.00
138.00% Upside
|
+5.9% |
|
IRWD
Ironwood Pharma
|
Aug 07, 2025 | HOLD |
Hold
+235.8% avg upside
23 analysts
|
$1.00
71.85% Downside
|
+300.0% |
|
PLRX
Pliant Therapeutics
|
Aug 07, 2025 | HOLD |
Buy
+1820.7% avg upside
21 analysts
|
$2.00
72.37% Upside
|
-26.8% |
|
FR:SAN
Sanofi
|
Jul 28, 2025 | BUY |
Strong Buy
+33.0% avg upside
30 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.